[医药制造业] [2023-12-04]
[医药制造业] [2023-12-04]
[仪器仪表制造业,医药制造业] [2023-12-01]
Vital signs provide critical information about a patient’s health to identify acute medical problems, indicate chronic diseases, and understand how the body copes with physiological stress. The normal ranges of the four major vital signs (body temperature, blood pressure, pulse, and breathing rate) vary with age, gender, weight, and the overall health of the person.
[医药制造业] [2023-12-01]
Medical equipment is an instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose.
[医药制造业] [2023-12-01]
Pharmaceuticals are chemical substances which are used as medicinal drugs for treating diseases. This industry discovers, develops, and manufactures medicines that are used to cure, alleviate symptoms, and vaccinate against various diseases.
[医药制造业,化学原料和化学制品制造业] [2023-11-30]
Product/Service Type: Esters Industry: Chemical Manufacturing
[医药制造业] [2023-11-29]
近日,微软展示了最新生物医学模型LLaVAMed,该模型可根据CT、X光图片等推测出患者的病理状况 。微软使用 GPT-4 ,基于 VisionTransformer和Vicuna语言模型,在八个英 伟达A100GPU上对LLaVA-Med进行训练,其中包含“每个图像的所有预分析信息”,用于生成有 关图像的问答,以满足“可自然语言回答有关生 物医学图像问题”的助手愿景。据微软称,该模型最终具有“出色的多模式对话能力”、“在用于回答视觉问题的三个标准生物医学数据集上,LLaVA-Med在部分指标上领先于业界其他先进模型”。
[医药制造业] [2023-11-29]
近年来利好政策迭出,鼓励创新药研发,加快上市审评速度。2015年以来,以鼓励药品创新,提升药品质量为导向,国家陆续出台了一系列针对新药注册的特殊审批管理规定。在优先评审、MAH制度、默认许可制等多重措施下,我国创新药行业在加快新药 注册步伐上取得了良好效果,更迅速地将创新药推向市场,从而促进国内创新药的发展,加速国内创新药企业的成长进程;此外,在多重利好政策下,国产创新药从“与国际接轨”到“出海”也在逐步实现。
[医药制造业] [2023-11-29]
Barnes Reports' Global Manufacturing & Makets report series provide estimates of the size and characteristics of the largest equipment, materials and consumables by manufacturing industries in the largest 140 global countries. These estimates are produced by a proprietary economic model that is based on a number of sources and factors
[医药制造业] [2023-11-28]
The administration of President Andrés Manuel López Obrador has been marked by a plethora of changes in health processes and regulations. Experts have questioned the clarity and sufficiency of some of these measures to meet the government’s ambitious and transformational goals for the sector.